We rank companies based on fund manager, research analyst and news sentiment
ARKG

ARK Genomic Revolution ETF
ARKG

$25.9
3.47%
0
Funds holding %
of 6,474 funds
Analysts bullish %
0
News positive %
of 3 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

41% more capital invested

Capital invested by funds: $435M [Q3] → $616M (+$181M) [Q4]

3.64% more ownership

Funds ownership: 25.11% [Q3] → 28.75% (+3.64%) [Q4]

6% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 48

1% less funds holding

Funds holding: 275 [Q3] → 272 (-3) [Q4]

25% less call options, than puts

Call options by funds: $51M | Put options by funds: $68.4M

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

34% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 96

Research analyst outlook

We haven’t received any recent analyst ratings for ARKG.

Financial journalist opinion

Based on 3 articles about ARKG published over the past 30 days